Back to Search
Start Over
Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim for Pneumocystis jiroveciipneumonia prophylaxis in patients with systemic rheumatic diseases receiving moderate-to high-dose glucocorticoids
- Source :
- Respiratory Investigation; November 2024, Vol. 62 Issue: 6 p1195-1201, 7p
- Publication Year :
- 2024
-
Abstract
- To compare the effectiveness and safety of low-dose sulfamethoxazole/trimethoprim (SMX/TMP) for Pneumocystis jiroveciipneumonia (PCP) prophylaxis in patients with systemic rheumatic disease (SRD) who were receiving glucocorticoids.
Details
- Language :
- English
- ISSN :
- 22125345
- Volume :
- 62
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Respiratory Investigation
- Publication Type :
- Periodical
- Accession number :
- ejs67721001
- Full Text :
- https://doi.org/10.1016/j.resinv.2024.10.007